Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor.
Atherosclerosis. 1997 Nov;135(1):119-30. doi: 10.1016/s0021-9150(97)00188-3.
Atherosclerosis. 1997.
PMID: 9395280
Preclinical review of cerivastatin sodium--a step forward in HMG-CoA reductase inhibition.
Bischoff H, Angerbauer R, Boberg M, Petzinna D, Schmidt D, Steinke W, Thomas G.
Bischoff H, et al. Among authors: angerbauer r.
Atherosclerosis. 1998 Sep;139 Suppl 1:S7-13. doi: 10.1016/s0021-9150(98)00188-9.
Atherosclerosis. 1998.
PMID: 9811153
Review.
Item in Clipboard
Biotransformation of cerivastatin in mice, rats, and dogs in vivo.
Boberg M, Angerbauer R, Kanhai WK, Karl W, Kern A, Radtke M, Steinke W.
Boberg M, et al. Among authors: angerbauer r.
Drug Metab Dispos. 1998 Jul;26(7):640-52.
Drug Metab Dispos. 1998.
PMID: 9660846
Item in Clipboard
Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved.
Boberg M, Angerbauer R, Fey P, Kanhai WK, Karl W, Kern A, Ploschke J, Radtke M.
Boberg M, et al. Among authors: angerbauer r.
Drug Metab Dispos. 1997 Mar;25(3):321-31.
Drug Metab Dispos. 1997.
PMID: 9172950
Item in Clipboard
Cite
Cite